Advisors Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,112	Closed	-$505K	–	530
2024 Q3	$505K	Buy	5,112 +37	+0.7%	+$3.63K	0.01%	367
2024 Q2	$471K	Sell	5,075 -121	-2%	-$10.8K	0.01%	367
2024 Q1	$493K	Buy	5,196 +77	+2%	+$7.14K	0.01%	361
2023 Q4	$457K	Buy	5,119 +556	+12%	+$41.3K	0.01%	356
2023 Q3	$333K	Buy	4,563 +248	+6%	+$19.8K	0.01%	345
2023 Q2	$359K	Sell	4,315 -493	-10%	-$41.2K	0.01%	352
2023 Q1	$366K	Buy	4,808 +427	+10%	+$35.4K	0.01%	337
2022 Q4	$364K	Buy	4,381 +549	+14%	+$44.4K	0.01%	348
2022 Q3	$322K	Sell	3,832 -957	-20%	-$80.7K	0.01%	385
2022 Q2	$356K	Buy	4,789 +1,712	+56%	+$129K	0.01%	338
2022 Q1	$277K	Buy	3,077 +732	+31%	+$67.6K	0.01%	379
2021 Q4	$263K	Buy	2,345 +395	+20%	+$47.6K	0.01%	382
2021 Q3	$245K	Buy	1,950 +17	+0.9%	+$2.19K	0.01%	378
2021 Q2	$262K	Sell	1,933 -140	-7%	-$18.4K	0.01%	345
2021 Q1	$281K	Buy	2,073 +108	+5%	+$16.2K	0.01%	323
2020 Q4	$276K	Sell	1,965 -203	-9%	-$26K	0.01%	306
2020 Q3	$242K	Buy	2,168 +37	+2%	+$4.15K	0.01%	281
2020 Q2	$239K	Buy	+2,131	New	+$210K	0.01%	268